Nanonization of Megestrol Acetate by Liquid Precipitation

被引:45
|
作者
Zhang, Zhi-Bing [1 ]
Shen, Zhi-Gang [1 ]
Wang, Jie-Xin [1 ]
Zhao, Hong [1 ]
Chen, Jian-Feng [2 ]
Yun, Jimmy [3 ]
机构
[1] Beijing Univ Chem Technol, Sin China Nano Technol Ctr, Key Lab Nanomat, Minist Educ, Beijing 100029, Peoples R China
[2] Beijing Univ Chem Technol, Res Ctr, Minist Educ High Grav Engn & Technol, Beijing 100029, Peoples R China
[3] Nanomat Technol Pte Ltd, Singapore 139959, Singapore
基金
中国国家自然科学基金;
关键词
WATER-SOLUBLE DRUGS; ANTISOLVENT PRECIPITATION; NANOPARTICLES; NANOSUSPENSIONS; FORMULATION; DISSOLUTION; THERAPY;
D O I
10.1021/ie900944y
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
The purpose of this study was to prepare megestrol acetate (MA) nanoparticles via a liquid precipitation technique. Several experimental parameters, such as the stabilizer combination, the volume ratio of antisolvent to drug solution, the temperature, the stirring speed, and the drying method were investigated. The as-prepared MA particles had a mean size of 208 nm, and 90% of the particles were distributed in the range of 100-300 nm, whereas the raw MA had a mean particle size of about 3.02 mu m, ranging widely from 0.2 mu m to 30,mu m. X-ray diffraction (XRD), differential scanning calorimetry (DSC), and Fourier transform infrared (FTIR) analysis indicated that MA nanoparticles exhibited decreased crystallinity and unchanged chemical group structure after precipitation. The freeze-dried MA nanoparticles exhibited improved wettability as demonstrated by the contact angle measurement result proving that particles were covered by a hydrophilic layer. In dissolution rate tests, the nanoparticles achieved 100% drug dissolution within 5 min, while the raw MA did not dissolve completely after 120 min, suggesting that the dissolution property of MA nanoparticles was significantly enhanced.
引用
收藏
页码:8493 / 8499
页数:7
相关论文
共 50 条
  • [31] ADRENAL INSUFFICIENCY INDUCED BY MEGESTROL ACETATE
    Rehman, H. A.
    George, M.
    Shah, K.
    Krodel, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (02) : 405 - 405
  • [32] MEGESTROL-ACETATE FOR ANOREXIA AND CACHEXIA
    LOPRINZI, CL
    JOHNSON, PA
    JENSEN, M
    ONCOLOGY, 1992, 49 : 46 - 49
  • [33] Characterization of related impurities in megestrol acetate
    Guo, Fujiang
    Feng, Huijin
    Wang, Youfu
    Zhang, Chune
    Li, Yuanchao
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2006, 41 (04) : 1418 - 1422
  • [34] Megestrol acetate in the spectrum of adrenal insufficiency
    Chan, AA
    ANNALS OF INTERNAL MEDICINE, 1998, 128 (12) : 1047 - 1047
  • [35] MEGESTROL-ACETATE AND APPETITE GAIN
    DONALD, SG
    VETERINARY RECORD, 1977, 101 (23) : 472 - 472
  • [36] MEGESTROL ACETATE FOR ESTRUS POSTPONEMENT IN BITCH
    BURKE, TJ
    REYNOLDS, HA
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1974, 165 (08) : 729 - 729
  • [37] MEGESTROL-ACETATE FOR TREATMENT OF ENDOMETRIOSIS
    SCHLAFF, WD
    DUGOFF, L
    DAMEWOOD, MD
    ROCK, JA
    OBSTETRICS AND GYNECOLOGY, 1990, 75 (04): : 646 - 648
  • [38] Serum levels of megestrol acetate,reproductive hormones and morphological changes in women using megestrol acetate silicone r
    谢衷明,徐美红,王忠兴,陈惠卿,毛全福
    生殖医学杂志, 1995, (S1) : 31 - 38
  • [39] Surgical window-of-opportunity study of megestrol acetate compared with megestrol acetate and metformin for endometrial intraepithelial neoplasia
    Xu, Yanfei
    Saiz, Allison
    Rimel, Bj
    Corr, Bradley
    Secord, Angeles Alvarez
    Clark, Leslie Horn
    Kocherginsky, Masha
    Schering, Tia
    Benante, Kelly A.
    Kalinichenko, Kiril
    Sauter, Edward
    Samimi, Goli
    Dimond, Eileen
    Khan, Seema Ahsan
    Barber, Emma Longley
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [40] Enthusiasm lacks data for megestrol acetate
    Christmas, C
    Finucane, TE
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (03) : 548 - 548